Citigroup
HRMY icon

Citigroup’s Harmony Biosciences HRMY Stock Holding History

Citigroup’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
70,086
-29,576
-30% -$933K ﹤0.01% 2746
2026
Q1 		$2.79M Sell
99,662
-54,878
-36% -$1.8M ﹤0.01% 2434
2025
Q4 		$5.78M Sell
154,540
-23,536
-13% -$774K ﹤0.01% 1913
2025
Q3 		$4.91M Sell
178,076
-3,973
-2% -$137K ﹤0.01% 1987
2025
Q2 		$5.75M Sell
182,049
-23,291
-11% -$749K ﹤0.01% 1774
2025
Q1 		$6.82M Buy
205,340
+5,539
+3% +$199K ﹤0.01% 1650
2024
Q4 		$6.88M Buy
199,801
+21,958
+12% +$754K ﹤0.01% 1665
2024
Q3 		$7.11M Buy
177,843
+15,859
+10% +$557K ﹤0.01% 1550
2024
Q2 		$4.89M Sell
161,984
-1,546
-0.9% -$46.5K ﹤0.01% 1638
2024
Q1 		$5.49M Sell
163,530
-3,489
-2% -$112K ﹤0.01% 1646
2023
Q4 		$5.39M Buy
167,019
+142,537
+582% +$3.98M ﹤0.01% 1541
2023
Q3 		$802K Sell
24,482
-8,167
-25% -$284K ﹤0.01% 2682
2023
Q2 		$1.15M Buy
32,649
+10,703
+49% +$369K ﹤0.01% 2734
2023
Q1 		$717K Sell
21,946
-6,415
-23% -$292K ﹤0.01% 2833
2022
Q4 		$1.56M Buy
28,361
+2,126
+8% +$117K ﹤0.01% 2237
2022
Q3 		$1.16M Buy
26,235
+5,965
+29% +$291K ﹤0.01% 2599
2022
Q2 		$989K Sell
20,270
-4,902
-19% -$221K ﹤0.01% 2660
2022
Q1 		$1.23M Buy
25,172
+4,030
+19% +$164K ﹤0.01% 2773
2021
Q4 		$901K Buy
21,142
+18,211
+621% +$726K ﹤0.01% 3361
2021
Q3 		$112K Buy
2,931
+785
+37% +$25.3K ﹤0.01% 4377
2021
Q2 		$61K Buy
2,146
+1,251
+140% +$37.5K ﹤0.01% 4721
2021
Q1 		$30K Sell
895
-424
-32% -$14.9K ﹤0.01% 5004
2020
Q4 		$48K Buy
+1,319
New +$53.2K ﹤0.01% 6059

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's HRMY Position: Q2 2026 in Review

Citigroup reduced its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, selling an estimated $933K and leaving 70,086 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

Citigroup first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.11M in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Citigroup held 70,086 shares of Harmony Biosciences worth $2.55M as of Q2 2026.
  • Citigroup sold 29,576 Harmony Biosciences shares in Q2 2026, an estimated $933K.
  • Harmony Biosciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2746 holding.
  • Citigroup first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's Harmony Biosciences position peaked at $7.11M in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.